NCT05694715: Combination Therapy in Cancers With Mutations in DNA Repair Genes

Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation, ATM Gene Mutation, PALB2 Gene Mutation